作者
S Wesley Long, Randall J Olsen, Shrenik C Mehta, Timothy Palzkill, Patricia L Cernoch, Katherine K Perez, William L Musick, Adriana E Rosato, James M Musser
发表日期
2014/11/1
期刊
Antimicrobial agents and chemotherapy
卷号
58
期号
11
页码范围
6668-6674
出版商
American Society for Microbiology
简介
Ceftaroline is the first member of a novel class of cephalosporins approved for use in the United States. Although prior studies have identified eight ceftaroline-resistant methicillin-resistant Staphylococcus aureus (MRSA) isolates in Europe and Asia with MICs ranging from 4 to 8 mg/liter, high-level resistance to ceftaroline (>32 mg/liter) has not been described in MRSA strains isolated in the United States. We isolated a ceftaroline-resistant (MIC > 32 mg/liter) MRSA strain from the blood of a cystic fibrosis patient and five MRSA strains from the respiratory tract of this patient. Whole-genome sequencing identified two amino acid-altering mutations uniquely present in the ceftaroline-binding pocket of the transpeptidase region of penicillin-binding protein 2a (PBP2a) in ceftaroline-resistant isolates. Biochemical analyses and the study of isogenic mutant strains confirmed that these changes caused ceftaroline resistance …
引用总数
201320142015201620172018201920202021202220232024111720241025161811172
学术搜索中的文章